Metabolomics

Dataset Information

0

Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type-2 diabetes

ABSTRACT: In this study we explored a unique cohort of 43 samples to build a map of metabolites varying in T2D across five different tissues (subcutaneous adipose tissue, liver, pancreatic islets, skeletal muscle and blood serum). The samples originate from the Excellence in Diabetes biobank (EXODIAB) in Sweden. To our knowledge, this is the first attempt to create a map of metabolites across various metabolic-relevant tissues for the same cohort of individuals. In total we identified 286 unique metabolites, 32% of which were significantly altered between non-diabetes and T2D. We found evidence that amino acids (AAs) and bile acids are elevated for specific tissues in T2D and significantly associated to the percentage of glycosylated hemoglobin A1c (HbA1c). We showed that carnitines and lysophosphatidylcholines (LPCs) are the most significantly altered metabolites in muscle, liver and serum in T2D. Finally, we attempted to explore the progression to overt T2D and suggest potential biomarkers in the early development of T2D, i.e. from non-diabetes to pre-diabetes to T2D.

INSTRUMENT(S): Agilent 6550 iFunnel Accurate-Mass UHPLC-QTOFMSMS (negative mode), LECO Pegasus III, GCTOFMS, Agilent 6550 iFunnel Accurate-Mass UHPLC-QTOFMSMS (positive mode)

SUBMITTER: Klev Diamanti 

PROVIDER: MTBLS690 | MetaboLights | 2018-10-08

REPOSITORIES: MetaboLights

Json Xml

Dataset's files

Source:
Action DRS
MTBLS690 Other
FILES Other
a_MTBLS690_azm_scilife_exodiab_metabolite_profiling_mass_spectrometry-1.txt Txt
a_MTBLS690_azm_scilife_exodiab_metabolite_profiling_mass_spectrometry-2.txt Txt
a_MTBLS690_azm_scilife_exodiab_metabolite_profiling_mass_spectrometry.txt Txt
Items per page:
1 - 5 of 11
altmetric image

Publications

Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes.

Diamanti Klev K   Cavalli Marco M   Pan Gang G   Pereira Maria J MJ   Kumar Chanchal C   Skrtic Stanko S   Grabherr Manfred M   Risérus Ulf U   Eriksson Jan W JW   Komorowski Jan J   Wadelius Claes C  

Scientific reports 20190704 1

Type 2 diabetes (T2D) mellitus is a complex metabolic disease commonly caused by insulin resistance in several tissues. We performed a matched two-dimensional metabolic screening in tissue samples from 43 multi-organ donors. The intra-individual analysis was assessed across five key metabolic tissues (serum, visceral adipose tissue, liver, pancreatic islets and skeletal muscle), and the inter-individual across three different groups reflecting T2D progression. We identified 92 metabolites differ  ...[more]

Similar Datasets

Proteomics Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes and normal tissues
2022-10-12 | PXD027597 | Pride
Transcriptomics Increased SRF Transcriptional Activity is a Novel Signature of Insulin Resistance in Humans and Mice
2011-03-01 | E-GEOD-25462 | biostudies-arrayexpress
Proteomics A Broad Network of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 Diabetes
2020-08-27 | PXD015430 | Pride
Transcriptomics Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using TALLYHO x C57BL6 F2 mice
2010-12-01 | E-GEOD-24637 | biostudies-arrayexpress
Transcriptomics A maple syrup extract alleviates liver injury in type 2 diabetic model mice
2020-01-13 | GSE134185 | GEO
Transcriptomics Affymetrix profiling of IMIDIA biobank samples from organ donors and partially pancreatectomized patients [partially pancreatectomized patient cohort]
2017-12-09 | GSE76895 | GEO
Transcriptomics Affymetrix profiling of IMIDIA biobank samples from organ donors and partially pancreatectomized patients [organ donor cohort]
2017-12-09 | GSE76894 | GEO
Metabolomics Integration of whole-body [18F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes
2020-01-06 | MTBLS1051 | MetaboLights
Transcriptomics Hepatic T-cell senescence is implicated in the progression of fatty liver disease in patients with type 2 diabetes
2023-08-05 | GSE239612 | GEO
Methylation profiling Different effects of bariatric surgery on epigenetic plasticity in skeletal muscle of individuals with and without type 2 diabetes [methylation array]
2024-07-17 | GSE272137 | GEO